on 23 Apr 2020
Last Applicant/ Owned by
JETEMA CO., LTD.
321, Joeom-ro, Jijeong-myeon, Wonju-si Gangwon-do 26355
, ,
Serial Number
UK00801536615 filed on 23rd Apr 2020
Registration Number
UK00801536615 registered on
4th Nov 2020
Correspondent Information
Sewon Patent Law Firm
11F. (Seocho-dong, Shinyoung Bldg.), 26 Saimdang-ro, Seocho-gu Seoul 06551
,
Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating muscle disorders; pharmaceutical agents affecting metabolism; poisons; anaesthetics; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for treating middle of the forehead wrinkles; pharmaceutical preparations for use in the cosmetic field; pharmaceuticals containing botulinum toxin; botulinum toxin; pharmaceutical preparations for urogenital organs; pharmaceutical preparations for plastic surgery; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; veterinary substances and preparations; cardiovascular agents for medical purposes; pharmaceutical preparations for treating neurological disorders; ophthalmic preparations; pharmaceutical preparations for treating facial cramps; allergy medications; chemical preparations for pharmaceutical purposes; chemico-pharmaceutical preparations; pharmaceutical preparations for treating facial wrinkles; pharmaceutical agents for epidermis; drugs for medical purposes; medicines for human purposes; pharmaceutical preparations for treating middle of the forehead wrinkles, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations for treating orthopaedic purposes; pharmaceutical preparations acting on the central nervous system; analgesic preparations; medicines for dental purposes; therapeutic drugs and agents; pharmaceutical preparations for treating pain; pharmaceutical products for skin care for medical purposes (including botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives); pharmaceutical preparations for treating neurological diseases (including botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives); pharmaceutical preparation for skin care; medicated preparations for skin treatment; pharmaceutical preparations for respiratory organs; preparations for the treatment of burns; preparations for the treatment of scar.
UK00801536615
Word
Individual